Wednesday, May 04, 2022

How common are medication-related errors in home care?

Peer-Reviewed Publication

WILEY

In a questionnaire-based study published in Pharmacology Research & Perspectives that included 485 fully trained nurses of 107 home care services, nearly half of all nursing staff made at least one error within the last year when administering medications.  

In the study, 41.6% of nurses reported medication errors within a 12-month period, and 14.8% did not provide an answer. Medication errors experienced by patients include taking the wrong dose or quantity of a particular drug, as well as omission of a drug or taking unlicensed drugs. 

Nurses who had attended medication training within the last 2 years were less likely to make errors. 

“The study results underline the need for regularly recurring medication training for nurses to ensure a high level of patient safety—especially in the home care sector, as nurses are the only professional group on site,” said lead author Sandra Strube-Lahmann, RN, MSc, PhD, of Charité - Universitätsmedizin Berlin, in Germany.

URL Upon Publication: https://onlinelibrary.wiley.com/doi/10.1002/prp2.953


About the Journal

Pharmacology Research & Perspectives is the outlet for fundamental and applied pharmacology. An official journal of the American Society for Pharmacology and Experimental Therapeutics and the British Pharmacological Society this gold open access journal publishes original research, reviews and perspectives in all areas of preclinical and clinical pharmacology, education and related research areas including articles that disprove a hypothesis.

About Wiley

Wiley is a global leader in research and education, unlocking human potential by enabling discovery, powering education, and shaping workforces. For over 200 years, Wiley has fueled the world’s knowledge ecosystem. Today, our high-impact content, platforms, and services help researchers, learners, institutions, and corporations achieve their goals in an ever-changing world. Visit us at  Wiley.com, like us on Facebook and follow us on Twitter and LinkedIn.

No comments: